Using tiny Probiotics to extend the lifespan of mighty humans: Probiotic Clostridium butyricum MIYAIRI 588 (CBM 588) increases CHIP levels, increases monoubiquitylation of insulin receptor (INSR), decreases INSR protein levels and enhances lifespan, via down regulation of its target gene, 26/February/2019, 8.26 am

Ribonucleic acid-based Lifespan extension therapy: A therapeutic mix encompassing lncRNA-NEAT1 and/or Melatonin, Ursolic acid, Maresin, DIM, Ursolic acid  Lutein, Maresin, Cholecalciferol, Catalpol, Isoliquiritigenin (MUMDULMCCI) activates autophagy, promotes leanness, increases insulin sensitivity, improves motor function, alleviates ageing feature and extends lifespan via upregulation of its target gene ATG5 (Autophagy-related 5), 26/February/2018, 12.37 am
February 25, 2019
Natural product-based therapy for inflammation and arthritis: Oridonin, found in Rabdosia Rubescens, increases IL-9 levels, augments proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis,  via up-regulation of its target genes, 26/February/2018, 8.40 am
February 26, 2019
Show all

Introduction: What they say 

A study from Institute for Cell Biology, University of Bonn, Ulrich-Haberland Str.  Bonn, Germany; and Institute for Genetics and CECAD Research Center, University of Cologne, Joseph-Stelzmann Str. Cologne, Germany shows that “The Ubiquitin Ligase CHIP Integrates Proteostasis and Aging by Regulation of Insulin Receptor Turnover.” This research paper was published, in the 20 April 2017 issue of the journal “Cell” [One of the best research journals in Biology with an I.F of 28 plus], by Prof. Hoppe T,Tawo R and others.


What we say:

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Using tiny Probiotics to extend the lifespan of mighty humans: Probiotic Clostridium butyricum MIYAIRI 588 (CBM 588) increases CHIP levels, increases monoubiquitylation of insulin receptor (INSR), decreases INSR protein levels and enhances lifespan, via down regulation of its target gene


What is known?

Prof. Hoppe T’s research team has recently shown that knocking down CHIP gene in mice results in a) increased protein levels of insulin receptor (INSR); and b) reduced lifespan. Further, they have shown that CHIP targets INSR for mono ubiquitylation and degradation, while its ability to degrade INSR is compromised upon proteotoxic stress and during ageing, as CHIP is directed toward disposal of misfolded proteins rather than degrade the INSR.


From Research findings to Therapeutic opportunity:

This study suggests a natural product-based anti-ageing therapy. A pharmaceutical mixture encompassing celecoxib and quercetin (CQ), by decreasing the expression of its target gene, it may increase the levels of CHIP (carboxy terminus of Hsc70 interacting protein). Thereby, it may: (1) increase CHIP-assisted proteolysis; (2) increase mono ubiquitylation and degradation of INSR; (3) inhibit the insulin and IGF1 signaling pathway; and (4) enhance longevity (Fig1).

Figure 1. Mechanistic insights into how probiotic Clostridium butyricum MIYAIRI 588 (CBM 588) induces CHIP expression and extends lifespan

Figure 2. Probiotic Clostridium butyricum MIYAIRI 588 (CBM 588) functions as a longevity promoter. 

Thus, pharmacological formulations encompassingprobiotic Clostridium butyricum MIYAIRI 588 (CBM 588), either alone or in combination with compounds,may be used to suppress age-associated overall physiological decline and improve health/life span.

[easy_payment currency=”USD”]


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How Clostridium butyricum MIYAIRI 588 (CBM 588) decreases the levels of INSR and promotes longevity

Amount:$300#

# Research cooperation


References:

Web: http://genomediscovery.org or http://newbioideas.com

Citation: Boominathan, L., Using tiny Probiotics to extend the lifespan of mighty humans: Probiotic Clostridium butyricum MIYAIRI 588 (CBM 588) increases CHIP levels, increases monoubiquitylation of insulin receptor (INSR), decreases INSR protein levels and enhances lifespan, via down regulation of its target gene, 26/February/2019, 8.26 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite us, kindly drop us a line at info@genomediscovery.org

Comments are closed.